{"id":54591,"date":"2025-11-13T18:22:26","date_gmt":"2025-11-13T12:52:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=54591"},"modified":"2025-11-13T18:22:47","modified_gmt":"2025-11-13T12:52:47","slug":"emcure-pharmaceuticals-q2-results-2025","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-q2-results-2025\/","title":{"rendered":"Emcure Pharmaceuticals Q2 Results 2025 Highlights: Net Profit Rises by 25.13% &#038; Revenue Up 13.38% YoY"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Q2 Results&nbsp;<\/em><\/strong><\/a><\/p><p><strong>Emcure Pharmaceuticals <\/strong><strong><em>Q2 Results FY26<\/em><\/strong>: During Q2 FY26, Emcure Pharmaceuticals&#8217; profit increased 25.13% YoY, while revenue increased by 13.38% YoY. The company posted robust numbers, with Q2 PAT at \u20b9243.46 crores and revenue at \u20b92,269.82 crores. <a href=\"https:\/\/univest.in\/stocks\/emcure\/emcure-pharmaceuticals-ltd-share-price-today\">Emcure Pharmaceuticals<\/a> announced its Q2 results on 11th November 2025.&nbsp;&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-q2-results-2025\/#Emcure_Pharmaceuticals_Q2_Results_FY26_Extracts_of_FY25_FY26\" title=\"Emcure Pharmaceuticals Q2 Results FY26: Extracts of FY25 &amp; FY26\">Emcure Pharmaceuticals Q2 Results FY26: Extracts of FY25 &amp; FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-q2-results-2025\/#Emcure_Pharmaceuticals_Q2_Results_FY26_Highlights_Q2_FY26_vs_FY25\" title=\"Emcure Pharmaceuticals Q2 Results FY26 Highlights (Q2 FY26 vs FY25)\">Emcure Pharmaceuticals Q2 Results FY26 Highlights (Q2 FY26 vs FY25)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-q2-results-2025\/#Emcure_Pharmaceuticals_Share_Price_Performance\" title=\"Emcure Pharmaceuticals Share Price Performance\">Emcure Pharmaceuticals Share Price Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-q2-results-2025\/#What_Analysts_Expect_Post_Q2_Results\" title=\"What Analysts Expect Post Q2 Results?\">What Analysts Expect Post Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-q2-results-2025\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Emcure_Pharmaceuticals_Q2_Results_FY26_Extracts_of_FY25_FY26\"><\/span><strong>Emcure Pharmaceuticals Q2 Results FY26: Extracts of FY25 &amp; FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Particulars<\/strong><\/td><td colspan=\"2\"><strong>Consolidated Figures<\/strong><\/td><td colspan=\"2\"><strong>Standalone Figures<\/strong><\/td><\/tr><tr><td><\/td><td><strong>30th Sep 2025<\/strong><\/td><td><strong>30 Sept 2024<\/strong><\/td><td><strong>30th Sept 2025<\/strong><\/td><td><strong>30th Sept 2024<\/strong><\/td><\/tr><tr><td><strong>Revenue from Operations<\/strong><\/td><td>\u20b92,269.82<\/td><td>\u20b92,001.98<\/td><td>\u20b91,260.60<\/td><td>\u20b91,104.63<\/td><\/tr><tr><td><strong>Profit Before Tax (PBT)<\/strong><\/td><td>\u20b9478.60<\/td><td>\u20b9416.53<\/td><td>\u20b9247.34<\/td><td>\u20b9207.09<\/td><\/tr><tr><td><strong>Profit After Tax (PAT)<\/strong><\/td><td>\u20b9243.46<\/td><td>\u20b9194.57<\/td><td>\u20b9117.62<\/td><td>\u20b986.92<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Emcure_Pharmaceuticals_Q2_Results_FY26_Highlights_Q2_FY26_vs_FY25\"><\/span><strong>Emcure Pharmaceuticals Q2 Results FY26 Highlights (Q2 FY26 vs FY25)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Emcure Pharmaceuticals clocked Q2 FY26 consolidated revenue of \u20b92,269.82 crores vs \u20b92,001.98 crores.\u00a0<\/li>\n\n<li>On the profit front, Emcure Pharmaceuticals earned a consolidated PAT of \u20b9243.46 crore in Q2 FY26. During FY25, the company\u2019s PAT stood at \u20b9194.57 crore.<\/li>\n\n<li>According to the consolidated figures, Emcure Pharmaceuticals&#8217; quarterly PAT increased by 25.13% YoY, while revenue increased by 13.38%.<\/li>\n\n<li>Emcure Pharmaceuticals clocked Q2 FY26 standalone revenue of \u20b91,260.60 crores vs \u20b91,104.63 crores.\u00a0<\/li>\n\n<li>On the profit front, Emcure Pharmaceuticals earned a standalone PAT of \u20b9117.62 crore in Q2 FY26. During FY25, the company\u2019s PAT stood at \u20b986.92 crore.<\/li>\n\n<li>According to the standalone figures, Emcure Pharmaceuticals&#8217; quarterly PAT increased by 35.32% YoY, while revenue increased by 14.12%.<\/li><\/ul><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Emcure_Pharmaceuticals_Share_Price_Performance\"><\/span><strong>Emcure Pharmaceuticals Share Price Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>On the opening bell on 13th November 2025, Emcure Pharmaceuticals shares opened at \u20b91,350.00 per share. However, the initial gains have since eroded, and Emcure Pharmaceuticals shares are currently trading at \u20b91,379.40 per share, which is higher than the opening price.&nbsp;&nbsp;&nbsp;&nbsp;<\/p><p>Considering the long-term achievements, Emcure Pharmaceuticals shares have yielded returns of approximately -1.88% over the past years, and 5-year returns stand at 4.10%. Over the maximum timeframe, Emcure Pharmaceuticals shares delivered a 0.93% return to investors.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Analysts_Expect_Post_Q2_Results\"><\/span><strong>What Analysts Expect Post Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Following Emcure Pharmaceuticals&#8217; robust Q2 results, analysts expect its share price to rise. According to analysts, Emcure Pharmaceuticals&#8217; share price is expected to reach \u20b91,495.30 per share in the coming year; however, in a downturn, it could fall to \u20b91,352.10 per share. However, one must ignore stock market volatility and invest in Emcure Pharmaceuticals after thorough research.&nbsp;<\/p><p><strong><em>Disclaimer:<\/em><\/strong><em> Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/nestle-q2-results-2025\">Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to \u20b9743.17 Crore; Revenue Up 10.57% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/inspira-enterprise-india-ipo-details\">Inspira Enterprise India IPO Details: Everything You Should Know about<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/swaraj-engines-q2-results-fy26\">Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to \u20b949 Crore; Revenue Up 8.62% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/hdb-financial-q2-results-2025\">HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to \u20b9581 Crore; Revenue Up 13.42% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bel-gears-q2-results-expectations\">BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/paytm-q2-results-expectations\">Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/blue-dart-q2-results-expectations\">Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click and Sign Up to Get Live Updates on Q2 Results&nbsp; Emcure Pharmaceuticals Q2 Results FY26: During Q2 FY26, Emcure Pharmaceuticals&#8217; profit increased 25.13% YoY, while revenue increased by 13.38% YoY. The company posted robust numbers, with Q2 PAT at \u20b9243.46 crores and revenue at \u20b92,269.82 crores. Emcure Pharmaceuticals announced its Q2 results on 11th<\/p>\n","protected":false},"author":23,"featured_media":54592,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3377],"class_list":["post-54591","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-emcure-pharmaceuticals-q2-results-2025"],"metadata":{"_edit_lock":["1763038368:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_title":["Emcure Pharmaceuticals Q2 Results 2025: Net Profit Rises 25.13% YoY"],"rank_math_description":["Discover the recent updates on the Emcure Pharmaceuticals Q2 results for FY26. Q2 profit rose 25.13% YoY to \u20b9243.48 crore, and revenue increased by 2,269.82% YoY. Learn more about the company's financials.\r\n"],"rank_math_focus_keyword":["Emcure Pharmaceuticals Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["54592"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["4635"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/emcure-pharmaceuticals-q2-results-2025"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/13181925\/Emcure-Pharmaceuticals-Q2-Results-2025-Net-Profit-Rises-25.13-YoY.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/54591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=54591"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/54591\/revisions"}],"predecessor-version":[{"id":54593,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/54591\/revisions\/54593"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/54592"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=54591"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=54591"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=54591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}